390 related articles for article (PubMed ID: 23564632)
1. Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality.
Stack AG; Hanley A; Casserly LF; Cronin CJ; Abdalla AA; Kiernan TJ; Murthy BV; Hegarty A; Hannigan A; Nguyen HT
QJM; 2013 Jul; 106(7):647-58. PubMed ID: 23564632
[TBL] [Abstract][Full Text] [Related]
2. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.
Xia X; He F; Wu X; Peng F; Huang F; Yu X
Am J Kidney Dis; 2014 Aug; 64(2):257-64. PubMed ID: 24176223
[TBL] [Abstract][Full Text] [Related]
3. Gout: an independent risk factor for all-cause and cardiovascular mortality.
Kuo CF; See LC; Luo SF; Ko YS; Lin YS; Hwang JS; Lin CM; Chen HW; Yu KH
Rheumatology (Oxford); 2010 Jan; 49(1):141-6. PubMed ID: 19933595
[TBL] [Abstract][Full Text] [Related]
4. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
[TBL] [Abstract][Full Text] [Related]
5. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
6. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
Liu WC; Hung CC; Chen SC; Yeh SM; Lin MY; Chiu YW; Kuo MC; Chang JM; Hwang SJ; Chen HC
Clin J Am Soc Nephrol; 2012 Apr; 7(4):541-8. PubMed ID: 22300737
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes.
Xia X; Zhao C; Peng FF; Luo QM; Zhou Q; Lin ZC; Yu XQ; Huang FX
Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):20-6. PubMed ID: 26712272
[TBL] [Abstract][Full Text] [Related]
9. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
[TBL] [Abstract][Full Text] [Related]
10. Long-term cardiovascular mortality among middle-aged men with gout.
Krishnan E; Svendsen K; Neaton JD; Grandits G; Kuller LH;
Arch Intern Med; 2008 May; 168(10):1104-10. PubMed ID: 18504339
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.
Nossent J; Raymond W; Divitini M; Knuiman M
BMC Cardiovasc Disord; 2016 Dec; 16(1):256. PubMed ID: 27978810
[TBL] [Abstract][Full Text] [Related]
12. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.
Perez-Ruiz F; Martínez-Indart L; Carmona L; Herrero-Beites AM; Pijoan JI; Krishnan E
Ann Rheum Dis; 2014 Jan; 73(1):177-82. PubMed ID: 23313809
[TBL] [Abstract][Full Text] [Related]
13. Low-level lead exposure and the prevalence of gout: an observational study.
Krishnan E; Lingala B; Bhalla V
Ann Intern Med; 2012 Aug; 157(4):233-41. PubMed ID: 22910934
[TBL] [Abstract][Full Text] [Related]
14. U-Shaped Association Between Serum Uric Acid Level and Risk of Mortality: A Cohort Study.
Cho SK; Chang Y; Kim I; Ryu S
Arthritis Rheumatol; 2018 Jul; 70(7):1122-1132. PubMed ID: 29694719
[TBL] [Abstract][Full Text] [Related]
15. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
16. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
[TBL] [Abstract][Full Text] [Related]
17. Is it time to revise the normal range of serum uric acid levels?
Desideri G; Castaldo G; Lombardi A; Mussap M; Testa A; Pontremoli R; Punzi L; Borghi C
Eur Rev Med Pharmacol Sci; 2014; 18(9):1295-306. PubMed ID: 24867507
[TBL] [Abstract][Full Text] [Related]
18. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
Baker JF; Schumacher HR; Krishnan E
Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of the CoLaus study to decipher the determinants of serum uric acid].
Bochud M; Vollenweider P; Waeber G
Rev Med Suisse; 2011 Nov; 7(315):2142, 2144-5. PubMed ID: 22187784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
